The clock is running out on one of the most consequential legal battles in mass tort history. With the Supreme Court’s term closing in late June 2026, a decision in Monsanto v. Durnell (No. 24-1068) could arrive at any moment — and when it does, it will either preserve or permanently extinguish tens of thousands of Roundup lawsuit 2026 claims filed by cancer survivors across the country. Today is June 23, 2026. The Court has roughly days, not weeks, left to act.
What Is Monsanto v. Durnell and Why Does It Matter Right Now
John Durnell is a Missouri farmer who developed non-Hodgkin lymphoma after decades of applying Roundup to his fields. In 2023, a Missouri jury awarded him $1.25 million on a failure-to-warn claim — finding that Monsanto failed to adequately disclose glyphosate’s cancer risks on its label. The Missouri Court of Appeals affirmed that verdict in February 2025, the Missouri Supreme Court declined review on April 1, 2025, and Monsanto petitioned the U.S. Supreme Court just three days later. The Court granted certiorari on January 16, 2026, and heard oral arguments on April 27, 2026.
The core legal question before the Court is whether the Federal Insecticide, Fungicide, and Rodenticide Act’s (FIFRA) uniformity clause — codified at 7 U.S.C. §136v(b) — expressly or impliedly preempts state-law failure-to-warn claims in cases where the EPA has not required a cancer warning on Roundup’s label. Monsanto argues its label is “preempted twice over”: once by the statute’s text, and again because EPA approval is required before any label change can take effect. If the Court sides with Monsanto broadly, the ruling would not just end Durnell’s case — it would wipe out the legal foundation underlying every pending Roundup lawsuit 2026 claim in the country.
The urgency cannot be overstated. Bayer itself confirmed in a press release that it “expects a decision on the merits during the Court’s 2026 session, which ends in June.” That window is now measured in days. For the approximately 65,000 claimants still in litigation — and the millions more who used Roundup and may have viable claims — the next ruling from One First Street will be among the most consequential in the history of pesticide mass tort litigation.
The Preemption Battle: Express vs. Implied, and What the Justices Signaled
Monsanto’s preemption argument rests on a structural tension that has divided courts for two decades. The EPA maintains that glyphosate is “not likely to be carcinogenic to humans.” The International Agency for Research on Cancer (IARC) reached the opposite conclusion in 2015, classifying glyphosate as “probably carcinogenic to humans.” State juries, applying state tort law, have repeatedly sided with plaintiffs — and Monsanto wants that entire category of litigation shut down by federal supremacy.
The Trump administration’s Department of Justice filed an amicus brief supporting Monsanto, with Principal Deputy Solicitor General Sarah Harris arguing that states cannot “second-guess or undermine” EPA’s pesticide registration decisions. That executive-branch alignment with a corporate defendant is significant: it signals that the federal government views state-court failure-to-warn verdicts as an intrusion on EPA’s regulatory authority, regardless of how those juries evaluate the underlying science.
Durnell’s legal team, backed by Earthjustice and environmental advocates, counters with the Supreme Court’s own 2005 precedent in Bates v. Dow Agrosciences, which held that EPA registration constitutes only “prima facie evidence” of compliance with federal labeling requirements — not a preemptive mandate that blocks all state law claims. The Bates decision has served as the legal backbone of Roundup litigation for years, and overturning or narrowing it would fundamentally reshape the landscape of pesticide injury law.
At oral argument on April 27, 2026, the Court did not appear unanimously enthusiastic about Monsanto’s broadest theory. Chief Justice Roberts, Justice Gorsuch, and Justice Jackson each pushed back on arguments that would categorically immunize pesticide manufacturers from state-law failure-to-warn liability whenever EPA has approved a label. The skepticism from across the ideological spectrum suggests the Court may be searching for a narrower ruling — but a narrow ruling against Durnell would still set damaging precedent for the pending Roundup lawsuit 2026 docket.
Bayer’s $7.25 Billion Settlement and the Opt-Out Deadline That Already Passed
On February 17, 2026, Bayer announced a $7.25 billion proposed class settlement covering current and future Roundup claimants. A Missouri judge granted preliminary approval on March 4, 2026. The settlement is tiered by exposure type and cancer severity, with the strongest occupational cases averaging approximately $165,000 per claimant. For context, this follows more than $10 billion Bayer has already spent resolving prior Roundup cases.
The critical procedural detail that every potential claimant needs to understand is this: the opt-out deadline passed on June 4, 2026. Individuals who did not affirmatively opt out of the class by that date may be bound by the settlement’s terms — and potentially barred from pursuing individual litigation regardless of how the Supreme Court rules. If you have not yet evaluated your options with qualified legal counsel, the window for individual action has likely closed for the class settlement itself.
The final approval hearing is scheduled for July 9, 2026 — deliberately placed after the expected Supreme Court ruling. This sequencing is not accidental. Settlement architects on both sides are waiting to see whether the Court’s decision makes individual litigation viable or legally impossible. If Monsanto wins broadly on preemption, Bayer’s leverage in any renegotiation increases dramatically. If Durnell prevails, claimants who opted out may find their individual cases far more valuable than what the settlement offers. To understand how settlement values are calculated in mass tort cases more broadly, a personal injury settlement calculator can provide useful context for evaluating compensation ranges.
Adding further procedural complexity, objectors removed the settlement to federal court on May 22, 2026, and Monsanto has moved to remand the case back to state court. The jurisdictional dispute over the settlement itself remains unresolved, layering additional uncertainty over an already extraordinarily volatile litigation landscape.
Key Statistics: The Roundup Litigation Landscape in 2026
| Metric | Figure | Source |
|---|---|---|
| Total Roundup claims filed (all time) | 100,000+ | Bayer AG / C&EN |
| Claims resolved in prior settlements | ~65,000 | Lawsuit Information Center / C&EN |
| Claims still pending as of 2026 | ~65,000 | C&EN / Bayer |
| Prior total resolution spend by Bayer | $10 billion+ | C&EN / Bayer AG |
| 2026 proposed class settlement value | $7.25 billion | Bayer press release, Feb. 17, 2026 |
| Average payout (strongest occupational cases) | ~$165,000 | JT NY Law analysis |
| Durnell original jury verdict | $1.25 million | Missouri jury, 2023; Bayer press release |
| SCOTUS cert granted | January 16, 2026 | Bayer press release |
| Oral arguments heard | April 27, 2026 | SCOTUSblog / C&EN |
| Opt-out deadline | June 4, 2026 | JT NY Law |
| Final settlement approval hearing | July 9, 2026 | JT NY Law / Lawsuit Information Center |
| State AGs supporting Durnell | 19 (18 states + New Mexico) | C&EN |
| State AGs supporting Monsanto | 3 (TX, FL, OH) | C&EN |
What a Monsanto Win — or Loss — Means for Every Claimant
A broad ruling for Monsanto would be catastrophic for the Roundup lawsuit 2026 litigation ecosystem. Tens of thousands of pending failure-to-warn claims — the dominant theory of liability in this litigation — could be dismissed before the July 9 final settlement approval hearing. Claimants who opted out of the class settlement in anticipation of pursuing individual litigation would find themselves with legally unviable claims and no fallback position. The precedential damage would extend far beyond Roundup: any plaintiff pursuing failure-to-warn claims against any EPA-registered pesticide manufacturer could face the same preemption barrier.
Earthjustice has warned that a Monsanto victory on the broadest preemption theory “could bar all lawsuits against companies who fail to warn people of known dangers of their pesticide products.” That is not hyperbole — it is a straightforward reading of what categorical FIFRA preemption would mean for the entire field of agricultural chemical injury litigation. The EPA’s current position that glyphosate is “not likely to be carcinogenic” would, under Monsanto’s theory, effectively immunize the company from all state-court accountability on warning adequacy.
A ruling for Durnell, by contrast, would preserve the existing framework under Bates, allow state-court failure-to-warn claims to proceed, and dramatically increase the settlement leverage of the approximately 65,000 claimants still in the pipeline. Bayer’s $7.25 billion settlement offer — already subject to objections — could face renewed pressure for upward revision if individual litigation remains viable. In wrongful death cases arising from Roundup-linked non-Hodgkin lymphoma, families should be aware that a wrongful death calculator can help estimate the full economic and non-economic value of a claim before any settlement decision is made.
Even a narrow ruling — one that resolves Durnell’s specific case without sweeping preemption language — would leave the litigation in a state of profound uncertainty. Lower courts would be left to parse whatever limiting principle the majority applies, and claimants would face years of additional jurisdictional battles before any stable legal framework emerged. The 22 state attorneys general who filed competing amicus briefs — 19 supporting Durnell, 3 supporting Monsanto — reflect the genuine national stakes of this decision for state regulatory authority and the health of agricultural workers across the country.
Frequently Asked Questions: Roundup Lawsuit 2026
What is the current status of the Roundup lawsuit in 2026?
As of June 23, 2026, the Supreme Court has heard oral arguments in Monsanto v. Durnell (No. 24-1068) and is expected to issue its decision before the Court’s term closes in late June 2026. The case will determine whether FIFRA preempts state-law failure-to-warn claims against Monsanto. Simultaneously, Bayer’s $7.25 billion proposed class settlement has received preliminary approval, the opt-out deadline passed June 4, and a final approval hearing is scheduled for July 9, 2026 — after the expected SCOTUS ruling. Approximately 65,000 claims remain pending.
Did the opt-out deadline for the Roundup class settlement already pass?
Yes. The deadline to opt out of Bayer’s $7.25 billion class settlement passed on June 4, 2026. Individuals who did not submit a timely opt-out may be bound by the settlement’s terms and barred from pursuing separate individual litigation. If you have a potential Roundup lawsuit 2026 claim and missed the opt-out deadline, you should consult a licensed attorney immediately to understand whether any exceptions or alternative legal theories remain available to you.
What would a Monsanto win at the Supreme Court mean for my Roundup claim?
A broad ruling in Monsanto’s favor on FIFRA preemption could extinguish tens of thousands of pending failure-to-warn claims — the primary legal theory underlying most Roundup lawsuit 2026 cases — before the July 9 final settlement hearing. Individuals who opted out of the class settlement to pursue individual litigation could find their standalone cases legally unviable. A narrow ruling against Durnell would create legal uncertainty without immediate mass dismissal, but would still set harmful precedent. A ruling for Durnell would preserve the existing legal framework and potentially increase individual claim values significantly.
What is the Bates v. Dow Agrosciences precedent and why does it matter in 2026?
The Supreme Court’s 2005 decision in Bates v. Dow Agrosciences held that EPA registration of a pesticide label constitutes only “prima facie evidence” of federal compliance — not a preemptive mandate that automatically bars all state-law failure-to-warn claims. For nearly two decades, Bates has served as the foundational precedent allowing Roundup lawsuit 2026 plaintiffs to bring their cases in state court. Monsanto is asking the Court to effectively overrule or severely limit Bates. If the Court does so, the legal basis for failure-to-warn claims against any EPA-registered pesticide manufacturer — not just Roundup — would be dramatically undermined.
How much is a Roundup lawsuit claim worth in 2026?
Settlement values under Bayer’s $7.25 billion class settlement are tiered by exposure type and cancer severity. The strongest occupational exposure cases — typically involving farmers, landscapers, and agricultural workers with direct, sustained contact — average approximately $165,000. Individual trial verdicts have been significantly higher; John Durnell’s 2023 Missouri verdict was $1.25 million, though that figure was for compensatory damages only, with punitive damages rejected. Prior to the class settlement, Bayer spent more than $10 billion resolving approximately 65,000 claims. The Supreme Court’s imminent ruling in Monsanto v. Durnell will profoundly affect whether individual claimants who opted out can realistically pursue — or recover more than — what the class settlement offers.
Legal Disclaimer: This article is provided for informational purposes only and does not constitute legal advice, establish an attorney-client relationship, or substitute for consultation with a licensed attorney regarding your specific legal situation.
Related reading: Ethylene Oxide Residential Exposure Verdict: How Industrial Sterilization Facilities Create Liability For Nearby Communities
Related reading: Ethylene Oxide Exposure Lawsuit Damages: How Communities Near Industrial Facilities Calculate Settlements & Verdicts
Victoria Chambers is a mass tort and class action research analyst with extensive knowledge of multi-district litigation (MDL), defective product cases, dangerous drug lawsuits, and toxic exposure claims across the United States. Victoria is not an attorney and the information provided is for educational purposes only.